Mode
Text Size
Log in / Sign up

Impact of Perineural Invasion on Survival Outcomes in Oral Squamous Cell CarcinomaPerineural invasion linked to poorer outcomes in oral squamous cell carcinoma

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Perineural invasion is a strong independent predictor of poor survival and increased local recurrence in OSCC.

This meta-analysis evaluates the prognostic implications of perineural invasion (PNI) in patients diagnosed with oral squamous cell carcinoma (OSCC). By synthesizing data from a large cohort of 23,580 patients, the study aims to quantify how the presence of nerve involvement influences clinical outcomes, specifically focusing on survival metrics and local recurrence rates. The findings provide a robust statistical foundation for using PNI as a critical biomarker in oncological staging.

Analysis of overall survival (OS) demonstrates that the presence of PNI is associated with a significantly higher hazard ratio (HR 1.67) for mortality. The confidence intervals remain tight, suggesting a consistent trend across the included studies. This indicates that patients with nerve involvement face a substantially higher risk of death compared to those without such involvement. The consistency of this finding across various cohorts underscores the reliability of PNI as a negative prognostic indicator.

Regarding disease-free survival (DFS), the data indicates a similar trend with an HR of 1.71. Patients with PNI exhibit a higher likelihood of disease progression or recurrence shortly after initial treatment. This suggests that PNI may facilitate local spread or indicate a more aggressive tumor phenotype. The statistical significance of this finding reinforces the need for vigilant monitoring in patients where nerve involvement is detected during surgical pathology.

Disease-specific survival (DSS) also showed a notable correlation with PNI, yielding an HR of 1.52. This metric isolates deaths specifically caused by the malignancy, further confirming that PNI is not just a marker of general frailty but a specific indicator of cancer progression. The consistency across OS, DFS, and DSS metrics provides a comprehensive view of the clinical impact of perineural involvement on the patient's trajectory. One of the most striking findings involves the risk of local recurrence (LR). The meta-analysis reported a high hazard ratio of 2.68 for patients with PNI. This substantial increase in risk suggests that PNI may serve as a primary indicator for local treatment failure. Clinicians can utilize this data to identify high-risk patients who may require more aggressive surgical margins or intensified adjuvant therapies to manage the risk of local spread.

While the study noted some moderate publication bias in survival outcomes, the overall results remained robust through sensitivity analyses. The consistent findings across multiple subgroups suggest that PNI is a reliable indicator for risk stratification. By identifying patients with PNI, clinicians can better tailor treatment plans, potentially escalating the intensity of and focus on regional management for those at highest risk of recurrence and poor survival.

How this fits prior evidence

How this fits prior evidence: This meta-analysis confirms the role of pathological and biological markers in risk stratification for oral squamous cell carcinoma. It complements other identified risk factors, such as a higher preoperative neutrophil-to-lymphocyte ratio which predicts poorer survival, and the use of circulating miRNAs for diagnosis. While other findings focus on imaging and nutritional support, this study reinforces the use of perineural invasion as a consistent prognostic indicator for survival and recurrence.

For people living with oral squamous cell carcinoma, understanding the specific characteristics of a tumor is vital for determining the best treatment plan. One specific factor that doctors look at is perineural invasion. This occurs when cancer cells are found traveling along or around the nerves in the mouth or jaw area. Identifying this feature helps medical teams understand how aggressive a cancer might be and how likely it is to spread or return after treatment.

To better understand this link, researchers conducted a large meta-analysis. This type of study combines the data from many different individual studies to find a clearer overall trend. This specific analysis looked at data from 57 different studies involving a total of 23,580 patients with oral squamous cell carcinoma. By pooling such a large number of cases, researchers can get a much clearer picture of how perineural invasion affects patient outcomes than they could by looking at just one small study.

The results showed a clear link between the presence of perineural invasion and poorer health outcomes. Specifically, patients whose tumors showed nerve involvement had a significantly lower chance of overall survival. The data also showed that these patients had a lower rate of disease-free survival and a lower rate of disease-specific survival. Furthermore, the risk of local recurrence, which is when the cancer returns in the same area after surgery or radiation, was significantly higher for patients with perineural invasion. The data showed that the risk of local recurrence was more than double for those with this specific finding.

While these findings are consistent, it is important to remember that this was a meta-analysis of existing studies, not a new clinical trial. The researchers also noted some moderate publication bias in the data regarding survival rates. This means that while the link between nerve involvement and poorer outcomes is robust and consistent, it is an association rather than a direct cause. The study shows a correlation between the presence of nerve involvement and the progression of the disease.

For patients and their families, this means that perineural invasion is a useful tool for doctors. It helps medical teams categorize the risk level of a patient's cancer. By identifying this risk early, doctors can make more informed decisions about surgical management and whether additional treatments, such as chemotherapy or radiation, are necessary. It provides a clearer roadmap for managing the specific needs of each patient based on the unique characteristics of their tumor.

What this means for you:
Perineural invasion is linked to higher recurrence rates and lower survival in oral squamous cell carcinoma.

Study Details

Study typeMeta analysis
Sample sizen = 23,580
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Oral squamous cell carcinoma (OSCC) remains a major global health challenge due to its high recurrence rate and poor prognosis. Perineural invasion (PNI), characterized by tumor cells infiltrating nerves, has been frequently reported in OSCC; however, its precise prognostic significance remains debated. To comprehensively clarify this, we performed a systematic review and meta-analysis assessing the prognostic impact of PNI on clinical outcomes in OSCC. Relevant studies published between 2015 and 2025 were systematically searched and selected, extracting hazard ratios (HR) for overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), and local recurrence (LR) from multivariate analyses. Fifty-seven eligible studies, encompassing 23,580 patients, were included. Meta-analysis demonstrated that the presence of PNI significantly correlated with worse OS (HR = 1.67; 95% CI: 1.49-1.87), DFS (HR = 1.71; 95% CI: 1.59-1.84), DSS (HR = 1.52; 95% CI: 1.35-1.72), and increased risk of LR (HR = 2.68; 95% CI: 1.70-4.24). Subgroup and sensitivity analyses confirmed robust and consistent prognostic associations, despite moderate publication bias in OS, DFS, and DSS outcomes. These findings provide strong evidence that PNI independently predicts adverse clinical outcomes in OSCC. Our results underscore the critical importance of incorporating PNI status into clinical risk stratification, guiding decisions on surgical management and adjuvant therapies. Future studies should focus on standardizing diagnostic methods and further elucidating underlying molecular mechanisms to optimize patient care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.